Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Opthea.
RELATED STOCKHEAD STORIES
News
Market Highlights and 5 ASX Small Caps to watch on Wednesday
Health & Biotech
ASX Health Stocks: Truscreen jumps 38% on business update, flagging strong growth in China
News
Market Highlights and 5 ASX Small Caps to watch on Wednesday
Health & Biotech
ASX Health Stocks: Pharmaxis progresses to Phase 2 study on bone marrow cancer
News
Market Highlights and 5 ASX Small Caps to watch on Tuesday
News
Trader’s Diary: Everything you need to get ready for the week ahead
Health & Biotech
ScoPo’s Powerplays: ‘Lots of money on sidelines waiting for pullbacks’, as all eyes are on earnings next week
Health & Biotech
ASX health stocks: Rhinomed rockets 80% after securing first government purchase for COVID-19 Rhinoswabs
Health & Biotech
ASX health stocks: EMV’s brain scanner is completed and ready for testing, stock price jumps 16pc
Health & Biotech
ScoPo’s Powerplays: Quarterlies to dictate price moves, as Nanosonics and Neuren come into play
Health & Biotech
The clinical ambitions of these two ASX biotechs just got a boost from the FDA
News
Market Highlights and 5 ASX Small Caps to watch on Tuesday
Health & Biotech
These ASX biotechs are on the verge of releasing Phase III clinical trial results
Health & Biotech
Budget review: Here’s what ASX biotech players thought of the ‘patent box’
News
Market Highlights and 4 ASX Small Caps to watch on Wednesday
Health & Biotech
AdAlta soars after getting orphan drug designation for its shark-based drug
News
